← Leaderboards
Qing Ma
State University Of New York At Buffalo
$2,602,110
Attributed
$4,605,179
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $832.9K · FY2012–24$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,605,179 · 2
By mechanism
R01$4,006,139 · 1
K08$599,040 · 1
Top collaborators
- Scott L Letendre5 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- William E Pelham$15,300,286
Others in their field
Top investigators on “Comorbidity”
- Judith S. Currier · University Of California Los Angeles$289,742,226
- Daniel R Kuritzkes · Brigham And Women'S Hospital$224,688,794
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$219,177,300
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$130,117,932
- Barbara Driver · Westat, Inc.$112,337,014
Research focus
ComorbidityDrug MetabolismDrug KineticsDosePathogenesisNeurotoxicityDrug DistributionToxic EffectSeveritiesPreventPharmaceutical PreparationsAntiretroviral TherapyNeurocognitiveAreaNeuroaidsBaseNeuraxisCognition DisordersCognitiveAdultCognitionCohortBloodAnti-Cholinergics
Grant awards (10)
Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV$751,792
R01 · FY2024 · AG · contact PI
Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV$783,353
R01 · FY2023 · AG · contact PI
Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV$815,809
R01 · FY2022 · AG · contact PI
Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV$832,882
R01 · FY2021 · AG · contact PI
Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV$822,303
R01 · FY2020 · AG · contact PI
Antiretroviral pharmacogenomics, pharmacokinetics and toxicity in neuroAIDS$119,936
K08 · FY2016 · MH · contact PI
Antiretroviral pharmacogenomics, pharmacokinetics and toxicity in neuroAIDS$119,776
K08 · FY2015 · MH · contact PI
Antiretroviral pharmacogenomics, pharmacokinetics and toxicity in neuroAIDS$119,776
K08 · FY2014 · MH · contact PI
Antiretroviral pharmacogenomics, pharmacokinetics and toxicity in neuroAIDS$119,776
K08 · FY2013 · MH · contact PI
Antiretroviral pharmacogenomics, pharmacokinetics and toxicity in neuroAIDS$119,776
K08 · FY2012 · MH · contact PI